Discovery of Dual-Acting Biofilm Inhibitors against Pseudomonas aeruginosa by the Coupling of 3-Hydroxypyridin-4(1 H )-ones with N -Phenylamide QS Inhibitors
Journal of Medicinal Chemistry · 24.07.2025 · 68 (14) · 14756-14781
DOI: 10.1021/acs.jmedchem.5c00909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 09.07.2025. Verfasst von Hao-Zhong Long und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, State Key Laboratory of Bioactive Molecules and Drug…. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Anti-Bacterial Agents, Quorum Sensing. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Pseudomonas aeruginosa (P. aeruginosa) is prevalent in hospital infections and strongly complicates the treatment for its propensity to cause biofilm-associated resistance. Herein, a series of novel dual-acting biofilm inhibitors were designed and synthesized by coupling 3-hydroxypyridin-4(1H)-ones with N-phenylamides quorum sensing inhibitors. The hit compound 19l (IC50 = 0.33 ± 0.06 μM) demonstrated significant biofilm inhibition compared to previously reported 3-hydroxypyridin-4(1H)-one derivatives in vitro. Mechanistic studies revealed that there was a decreased production of virulence regulated by quorum sensing system and a lack of iron acquisition under the treatment of 19l, which led to the inhibition of biofilm. More importantly, 19l demonstrated significant antibacterial synergistic effects in the mice wound infection model, enhancing the antibacterial activity of ciprofloxacin and tobramycin by 1000-fold and 200-fold, respectively. Therefore, our study highlighted the clinical application potential of dual-acting biofilm inhibitory strategies and 19l may be a potent antibacterial synergist to combat P. aeruginosa infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Pharmacy, Jinan University, Guangzhou…
- Institute for Advanced and Applied Chemical Synthesis, Jinan University, Guangzhou 510632, P. R. China.
ORCID-Profile: Jing Lin, Wei-Min Chen, Jun Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Long, H. Z., Tang, W., Huang, M. Y., Yang, G. B., Hu, X. B., Liu, Y. T., Mo, X. X., Lin, J., Chen, W. M., & Liu, J. (2025). Discovery of Dual-Acting Biofilm Inhibitors against Pseudomonas aeruginosa by the Coupling of 3-Hydroxypyridin-4(1 H )-ones with N -Phenylamide QS Inhibitors. Journal of Medicinal Chemistry, 68(14), 14756-14781. https://doi.org/10.1021/acs.jmedchem.5c00909
Vancouver
Long HZ, Tang W, Huang MY, Yang GB, Hu XB, Liu YT, et al. Discovery of Dual-Acting Biofilm Inhibitors against Pseudomonas aeruginosa by the Coupling of 3-Hydroxypyridin-4(1 H )-ones with N -Phenylamide QS Inhibitors. Journal of Medicinal Chemistry. 2025;68(14):14756-14781. doi:10.1021/acs.jmedchem.5c00909
BibTeX
@article{Long2025,
author = {Long, Hao-Zhong and Tang, Wei and Huang, Mei-Yan and Yang, Guo-Bin and Hu, Xi-Bing and Liu, Ya-Ting and Mo, Xiao-Xin and Lin, Jing and Chen, Wei-Min and Liu, Jun},
title = {Discovery of Dual-Acting Biofilm Inhibitors against Pseudomonas aeruginosa by the Coupling of 3-Hydroxypyridin-4(1 H )-ones with N -Phenylamide QS Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {14},
pages = {14756--14781},
doi = {10.1021/acs.jmedchem.5c00909}
}
EUVIMED